Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SMBC Nikko Downgrades Jounce Therapeutics to Neutral

SMBC Nikko analyst David Dai downgrades Jounce Therapeutics (NASDAQ:JNCE) from Outperform to Neutral.
byBenzinga Newsdesk
February 24, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

SMBC Nikko analyst David Dai downgrades Jounce Therapeutics (NASDAQ:JNCE) from Outperform to Neutral.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts